Progress toward the development of universal influenza vaccines

Area of Science:

• * Virology and Immunology
• * Vaccine Development

Background:

• * Influenza viruses cause substantial annual morbidity and mortality.
• * Pandemics pose a significant global health threat with high mortality potential.
• * Current seasonal vaccines require annual reformulation to match circulating strains.

Purpose of the Study:

• * To develop cross-protective influenza vaccines.
• * To induce T cell and/or antibody responses against conserved viral epitopes.
• * To create universally relevant influenza vaccine candidates.

Main Methods:

• * Focus on identifying and targeting highly conserved viral epitopes.
• * Research into inducing robust T cell and antibody-mediated immunity.
• * Leveraging expertise at the Saint Louis University Center for Vaccine Development (SLUCVD).

Main Results:

• * Ongoing research efforts are underway.
• * SLUCVD is actively engaged in multiple vaccine development initiatives.
• * Progress is being made towards universally applicable influenza vaccines.

Conclusions:

• * Developing universal influenza vaccines is crucial for pandemic preparedness.
• * Targeting conserved epitopes offers a promising strategy for broad protection.
• * Continued research is essential to combat the global influenza threat.